Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2448-2460

  Gao, Pan ^a   Meng, Xian Fang ^a   Su, Hua ^a   He, Fang Fang ^a   Chen, Shan ^a   Tang, Hui ^a   Tian, Xiu Juan ^a   Fan, Di ^a   Wang, Yu Mei ^a   Liu, Jian She ^a   Zhu, Zhong Hua ^a   Zhang, Chun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diabetic nephropathy; NALP3 inflammasome; Podocyte; TXNIP

Indexed keywords

CRYOPYRIN; GLUCOSE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; SHORT HAIRPIN RNA; SYNAPTOPODIN; THIOREDOXIN INTERACTING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; GLOMERULAR INJURY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

EID: 84905254968     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.07.001     Document Type: Article

References (42)

1. Goh S.Y., Jasik M., Cooper M.E. Agents in development for the treatment of diabetic nephropathy. Expert Opin. Emerg. Drugs 2008, 13:447-463.
2. Atkins R.C., Zimmet P. Diabetic kidney disease: act now or pay later. Saudi J. Kidney Dis. Transplant. 2010, 21:217-221.
3. Dagogo-Jack S. Primary prevention of type-2 diabetes in developing countries. J. Natl. Med. Assoc. 2006, 98:415-419.
4. Collins A.J., Foley R.N., Chavers B., Gilbertson D., Herzog C., Johansen K., Kasiske B., Kutner N., Liu J., St Peter W., Guo H., Gustafson S., Heubner B., Lamb K., Li S., Peng Y., Qiu Y., Roberts T., Skeans M., Snyder J., Solid C., Thompson B., Wang C., Weinhandl E., Zaun D., Arko C., Chen S.C., Daniels F., Ebben J., Frazier E., Hanzlik C., Johnson R., Sheets D., Wang X., Forrest B., Constantini E., Everson S., Eggers P., Agodoa L. United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am. J. Kidney Dis. 2012, 59:A7,e1-420.
5. Miyauchi M., Toyoda M., Kobayashi K., Abe M., Kobayashi T., Kato M., Yamamoto N., Kimura M., Umezono T., Suzuki D. Hypertrophy and loss of podocytes in diabetic nephropathy. Intern. Med. 2009, 48:1615-1620.
6. Menini S., Iacobini C., Oddi G., Ricci C., Simonelli P., Fallucca S., Grattarola M., Pugliese F., Pesce C., Pugliese G. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Diabetologia 2007, 50:2591-2599.
7. Reidy K., Susztak K. Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. Am. J. Kidney Dis. 2009, 54:590-593.
8. Yamaguchi Y., Iwano M., Suzuki D., Nakatani K., Kimura K., Harada K., Kubo A., Akai Y., Toyoda M., Kanauchi M., Neilson E.G., Saito Y. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am. J. Kidney Dis. 2009, 54:653-664.
9. Steffes M.W., Schmidt D., McCrery R., Basgen J.M. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int. 2001, 59:2104-2113.
10. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., Nelson R.G., Myers B.D., Rennke H.G., Coplon N.S., Sun L., Meyer T.W. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 1997, 99:342-348.
11. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Girma M., Erickson S., Dixit V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430:213-218.
12. Petrilli V., Dostert C., Muruve D.A., Tschopp J. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 2007, 19:615-622.
13. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., Dixit V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
14. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27:229-265.
15. Kanneganti T.D., Body-Malapel M., Amer A., Park J.H., Whitfield J., Franchi L., Taraporewala Z.F., Miller D., Patton J.T., Inohara N., Nunez G. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 2006, 281:36560-36568.
16. Martinon F., Petrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
17. Niemir Z.I., Stein H., Dworacki G., Mundel P., Koehl N., Koch B., Autschbach F., Andrassy K., Ritz E., Waldherr R., Otto H.F. Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int. 1997, 52:393-403.
18. Iyer S.S., Pulskens W.P., Sadler J.J., Butter L.M., Teske G.J., Ulland T.K., Eisenbarth S.C., Florquin S., Flavell R.A., Leemans J.C., Sutterwala F.S. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20388-20393.
19. Zhang C., Boini K.M., Xia M., Abais J.M., Li X., Liu Q., Li P.L. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension 2012, 60:154-162.
20. Vilaysane A., Chun J., Seamone M.E., Wang W., Chin R., Hirota S., Li Y., Clark S.A., Tschopp J., Trpkov K., Hemmelgarn B.R., Beck P.L., Muruve D.A. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J. Am. Soc. Nephrol. 2010, 21:1732-1744.
21. Babelova A., Moreth K., Tsalastra-Greul W., Zeng-Brouwers J., Eickelberg O., Young M.F., Bruckner P., Pfeilschifter J., Schaefer R.M., Grone H.J., Schaefer L. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J. Biol. Chem. 2009, 284:24035-24048.
22. Jones L.K., O'Sullivan K.M., Semple T., Kuligowski M.P., Fukami K., Ma F.Y., Nikolic-Paterson D.J., Holdsworth S.R., Kitching A.R. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol. Dial. Transplant. 2009, 24:3024-3032.
23. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11:136-140.
24. Oslowski C.M., Hara T., O'Sullivan-Murphy B., Kanekura K., Lu S., Hara M., Ishigaki S., Zhu L.J., Hayashi E., Hui S.T., Greiner D., Kaufman R.J., Bortell R., Urano F. Thioredoxin-interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome. Cell Metab. 2012, 16:265-273.
25. Advani A., Gilbert R.E., Thai K., Gow R.M., Langham R.G., Cox A.J., Connelly K.A., Zhang Y., Herzenberg A.M., Christensen P.K., Pollock C.A., Qi W., Tan S.M., Parving H.H., Kelly D.J. Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J. Am. Soc. Nephrol. 2009, 20:730-741.
26. Kaimul A.M., Nakamura H., Masutani H., Yodoi J. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic. Biol. Med. 2007, 43:861-868.
27. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327:296-300.
28. Chen J., Saxena G., Mungrue I.N., Lusis A.J., Shalev A. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes 2008, 57:938-944.
29. Liu B.C., Song X., Lu X.Y., Li D.T., Eaton D.C., Shen B.Z., Li X.Q., Ma H.P. High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species. Biochim. Biophys. Acta 2013, 1833:1434-1442.
30. He F.F., Zhang C., Chen S., Deng B.Q., Wang H., Shao N., Tian X.J., Fang Z., Sun X.F., Liu J.S., Zhu Z.H., Meng X.F. Role of CD2-associated protein in albumin overload-induced apoptosis in podocytes. Cell Biol. Int. 2011, 35:827-834.
31. Zhang C., Hu J.J., Xia M., Boini K.M., Brimson C.A., Laperle L.A., Li P.L. Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene. Free Radic. Biol. Med. 2010, 48:1109-1117.
32. Toyonaga J., Tsuruya K., Ikeda H., Noguchi H., Yotsueda H., Fujisaki K., Hirakawa M., Taniguchi M., Masutani K., Iida M. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. Nephrol. Dial. Transplant. 2011, 26:2475-2484.
33. Junn E., Han S.H., Im J.Y., Yang Y., Cho E.W., Um H.D., Kim D.K., Lee K.W., Han P.L., Rhee S.G., Choi I. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J. Immunol. 2000, 164:6287-6295.
34. Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 1999, 274:21645-21650.
35. Segelmark M., Hellmark T. Autoimmune kidney diseases. Autoimmun. Rev. 2010, 9:A366-A371.
36. Cassel S.L., Sutterwala F.S. Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur. J. Immunol. 2010, 40:607-611.
37. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.
38. Larsen C.M., Faulenbach M., Vaag A., Volund A., Ehses J.A., Seifert B., Mandrup-Poulsen T., Donath M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 2007, 356:1517-1526.
39. Sen U., Basu P., Abe O.A., Givvimani S., Tyagi N., Metreveli N., Shah K.S., Passmore J.C., Tyagi S.C. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am. J. Physiol. Ren. Physiol. 2009, 297:F410-F419.
40. Zou J., Yaoita E., Watanabe Y., Yoshida Y., Nameta M., Li H., Qu Z., Yamamoto T. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch. 2006, 448:485-492.
41. Mundel P., Heid H.W., Mundel T.M., Kruger M., Reiser J., Kriz W. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J. Cell Biol. 1997, 139:193-204.
42. Hamada Y., Fukagawa M. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Kobe J. Med. Sci. 2007, 53:53-61.